Article
Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United States.
American journal of obstetrics and gynecology - 1 Feb 2024
Wheeler Cosette M, Torrez-Martinez Norah E, Torres-Chavolla Edith, Parvu Valentin, Andrews Jeffrey C, Du Ruofei, Robertson Michael, Joste Nancy E, Cuzick Jack
Abstract excerpt
BACKGROUND: The US Food and Drug Administration supports innovations to facilitate new indications for high-risk human papillomavirus testing. This report describes the retrospective testing of stored specimens and analysis of existing data to efficiently and cost-effectively support a new indication for the Onclarity human papillomavirus assay (Becton, Dickinson and Company, BD Life Sciences - Integrated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
